AMT-676

· Multitude Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMT-676, covering 2025-05-02 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer [Phase 2]